Laddar...
In vivo cancer vaccination: which dendritic cells to target and how?
The field of cancer immunotherapy has been revolutionized with the use of immune checkpoint blockade antibodies such as anti-programmed cell death 1 protein (PD-1) and chimeric antigen receptor T cells. Significant clinical benefits are observed in different cancer types with these treatments. While...
Sparad:
| I publikationen: | Cancer Treat Rev |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6295330/ https://ncbi.nlm.nih.gov/pubmed/30390423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2018.10.012 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|